Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2005-05-03
2005-05-03
Brumback, Brenda (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C424S085100, C514S002600, C514S012200
Reexamination Certificate
active
06887461
ABSTRACT:
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e.g., oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e.g., psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e.g., conjunctivitis, retinitis, and uveitis).
REFERENCES:
patent: 4808613 (1989-02-01), Kaneko et al.
patent: 5215895 (1993-06-01), Bennet et al.
patent: 5270181 (1993-12-01), McCoy et al.
patent: 5292646 (1994-03-01), McCoy et al.
patent: 5425950 (1995-06-01), Dandiker et al.
patent: 5679339 (1997-10-01), Keith et al.
patent: 5700664 (1997-12-01), Yang et al.
patent: 5958401 (1999-09-01), Keith et al.
patent: 6190691 (2001-02-01), Mak
patent: WO 9204455 (1992-03-01), None
Siadati and Sarr.(1998). Role of extrinsic innervation in release of motilin and patterns of upper gut canine motility.J. Gastrointest. Sur. 2(4): 363-72.
Luiking, et al.(1998). Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.Gut42(6): 830-5.
Depoortere, et al. (1997). Distribution and subcellular localization of motilin binding sites in the rabbit brain.Brain Res. 777(1-2):103-9.
Van Assche, et al. (1997). Concentration-dependent stimulation of cholinergic motor nerves or smooth muscle by [Nle 13]motilin in the isolated rabbit gastric antrum.Eur. J. Pharmacol. 337(2-3): 267-74.
Tomita, et al. (1997). The role of motilin and cisapride in the enteric nervous system of the lower esophageal sphincter in humans.Surg. Today. 27(11): 985-92.
Boivin et al. (1997). Neural mediation of the motilin motor effect on the human antrum.Am. J. Physiol. 272(1 Pt 1): G71-6.
Yokoyama, et al. (1995). Recovery of gastrointestinal motility from post-operative ileus in dogs: effects of Leu13-motilin (KW-5139) and prostaglandin F2 alpha.Neurogastroenterol. Motil. 7(4): 199-210.
De Clercq, et al. (1998). Motilin in human milk: identification and stability during digestion.Life Sci. 63(22): 1993-2000.
Ordaz-Jimenez, et al. (1998). [Gastrointestinal hormones during minimal enteral feeding of sick premature infants]Rev. Invest. Clin. 50(1): 37-42. (Spanish w/English abstract).
Jadcherla, et al. (1997). Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants.Pediatr. Res. 42(3): 365-9.
Omura , et al. (1987). Macrolides with gastrointestinal motor stimulating activity.J Med Chem. 30(11): 1941-3.
Werch, et al (1997). Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro.Blood.90(10): 3893-902.
Orazi, et al. (1996). Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.Exp. Hematol. 24(11): 1289-97.
Du, et al. (1997). Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis.Am. J. Physiol.272(3 Pt 1): G545-52.
Orazi , et al. (1996). Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation.Lab. Invest. 75(1): 33-42.
Keith, et al. (1994). “IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.”Stem Cells. 12(Suppl 1):79-90.
Qiu, et al.. (1996). Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats.Dig. Dis. Sci. 41(8): 1625-30.
Hill, et al. (1998). Interleukin-11 promotes T cell polarization and prevents acute graft-versus host disease after allogeneic bone marrow transplantation.J. Clin. Invest. 102(1): 115-23.
Redlich, et al. (1996). IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury.J. Immunol. 157(4): 1705-10.
Waxman , et al. (1998) Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.J Clin Invest. 101(9):1970-82.
Leng and Elias (1997). Interleukin-11 inhibits macrophage interleukin-12 production.J. Immunol. 159(5): 2161-8.
Trepicchio, et al. (1997). IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB.J. Immunol. 159(11): 5661-70.
Trepicchio, et al. (1996). Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.J. Immunol. 157(8): 3627-34.
Taga and Kishimoto (1997). Gp130 and the interleukin-6 family of cytokines.Annu. Rev. Immunol. 15:797-819.
Zhang, et al. (1994). Ciliary neurotropic factor, interleukin-11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.J. Exp. Med. 179(4):1337-42.
Yang and Yin.(1995). Interleukin (IL)-11—mediated signal transduction.Ann. NY Acad. Sci. 762: 31-41.
Nandurkar, et al. (1996). The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.Oncogene. 12(3):585-93.
Miyatake, et al. (1998). Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.J. Immunol. 160(8): 4114-23.
Yin, et al. (1994). Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer.Exp. Hematol. 22(5): 467-72.
Wang, et al. (1995). Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells.J. Biol. Chem. 270(47): 27999-8002.
Lutticken, et al. (1994). Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.Science 263(5143): 89-92.
Hemmann, et al. (1996). Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130.J. Biol. Chem. 271(22): 12999-3007.
Zhong, et al. (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.Science. 264(5155): 95-8.
Akira (1997). IL-6-regulated transcription factors. Int. J. Biochem. Cell Biol. 29(12):1401-18.
Zhang, et al. (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes.Science 267(5206): 1990-4.
Boulton, et al. (1995), STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.Proc. Natl. Acad. Sci. USA. 92(15): 6915-9.
Adunyah, et al. (1995). Interleukin-11 induces tyrosine phosphorylation, and c-jun and c-fos mRNA expression in human K562 and U937 Cells.Ann. NY Acad. Sci. 766:296-9.
Yin and Yang (1994). Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells.J. Biol. Chem. 269(5): 3731-8.
Paul, et al. (1990). Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.Proc. Natl. Acad. Sci. USA. 87(19):7512-6.
Balkwill and Burke (1989). The cytokine network.Immunol Today 10(9): 299-304.
Wong and Clark (1988). Multiple actions of interleukin 6 within a cytokine network.Immunol. Today.(5); 137-9.
Clark and Kamen (1987). The human hematopoietic colony-stimulating factors.Science.236(4806): 1229-37.
Jacobs, et al. (1970). Characteristics of a human diploid cell designated MRC-5.Nature 227(254): 168-70.
Ikebuchi, et al. (1988). Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor.Blood 72(6): 2007-14.
Bruno, et al. (1991). Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells.Exp. Hematol. 19(5): 378-81.
Bedrosian Camille L.
Keith, Jr. James C.
Schendel Paul F.
Schwertschlag Ullrich S.
Warne Nick W.
Brumback Brenda
Elrifi Ivor R.
Genetics Institute LLC
Johnson David E.
Mintz Levin
LandOfFree
Method of using IL-11 for treating mucositis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using IL-11 for treating mucositis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using IL-11 for treating mucositis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380240